Care plan study for people on blood thinners having abdominal surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at whether a structured (protocol-based) care plan before and around surgery improves outcomes for people taking blood-thinning medicines. It may help teams plan safer timing and monitoring to reduce complications around the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently take a blood thinner or blood-clot-preventing medicine (antiplatelet and/or anticoagulant) for more than 2 weeks
- You have one of these higher-risk reasons: atrial fibrillation (score over 4), a previous artificial heart valve, a recent or high-risk blood clot in the veins, recent/serious heart circulation disease (like a stent or heart attack), a recent stroke/TIA, or blocked arteries in the legs
- Your doctors plan intra-abdominal surgery (for example, belly or urologic surgery)
- Surgery is not an emergency—you have time for pre-surgery assessment
- You can complete the pre-surgery evaluation and the follow-up plan, and you agree to participate in writing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best way to manage your blood-thinning medicine (antiplatelet therapy) around the time of abdominal surgery, if you have a coronary stent. The goal is to help reduce the risk of heart problems while keeping bleeding risks low.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This study looks at whether a virtual visit can safely manage your blood thinners around the time of a planned surgery. You would stop your medication before the procedure and restart it after, but all instructions and check-ins happen remotely (phone or video).
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
Hear when a new Antithrombotic Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.